{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:51:51Z","timestamp":1790740311390,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T00:00:00Z","timestamp":1397001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T00:00:00Z","timestamp":1397001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s10637-014-0076-7","type":"journal-article","created":{"date-parts":[[2014,4,8]],"date-time":"2014-04-08T01:22:48Z","timestamp":1396920168000},"page":"598-603","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Small-molecule inhibition of oncogenic eukaryotic protein translation in mesothelioma cells"],"prefix":"10.1007","volume":"32","author":[{"given":"Esther Z.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniekan M.","family":"Okon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek J.","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Bitterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carston R.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Kratzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,9]]},"reference":[{"key":"76_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1053\/sonc.2002.30237","volume":"29","author":"M Britton","year":"2002","unstructured":"Britton M (2002) The epidemiology of mesothelioma. Semin Oncol 29:18\u201325","journal-title":"Semin Oncol"},{"key":"76_CR2","doi-asserted-by":"publisher","first-page":"6959","DOI":"10.1038\/sj.onc.1210515","volume":"26","author":"M Carbone","year":"2007","unstructured":"Carbone M, Albelda SM, Broaddus VC et al (2007) Eighth international mesothelioma interest group. Oncogene 26:6959\u20136967","journal-title":"Oncogene"},{"key":"76_CR3","doi-asserted-by":"crossref","first-page":"7843","DOI":"10.1016\/S0021-9258(17)39529-7","volume":"260","author":"LS Hiremath","year":"1985","unstructured":"Hiremath LS, Webb NR, Rhoads RE (1985) Immunological detection of the messenger RNA cap-binding protein. J Biol Chem 260:7843\u20137849","journal-title":"J Biol Chem"},{"key":"76_CR4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0021-9258(19)75938-9","volume":"262","author":"R Duncan","year":"1987","unstructured":"Duncan R, Milburn SC, Hershey JW (1987) Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. Heat shock effects on eIF-4F. J Biol Chem 262:380\u2013388","journal-title":"J Biol Chem"},{"key":"76_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nrc2824","volume":"10","author":"D Silvera","year":"2010","unstructured":"Silvera D, Formenti SC, Schneider RJ (2010) Translational control in cancer. Nat Rev Cancer 10:254\u2013266","journal-title":"Nat Rev Cancer"},{"key":"76_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2007.08.022","volume":"258","author":"SC Thumma","year":"2007","unstructured":"Thumma SC, Kratzke RA (2007) Translational control: a target for cancer therapy. Cancer Lett 258:1\u20138","journal-title":"Cancer Lett"},{"key":"76_CR7","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.cell.2009.01.042","volume":"136","author":"N Sonenberg","year":"2009","unstructured":"Sonenberg N, Hinnebusch AG (2009) Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136:731\u2013745","journal-title":"Cell"},{"key":"76_CR8","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.1158\/1078-0432.CCR-10-0433","volume":"16","author":"AC Hsieh","year":"2010","unstructured":"Hsieh AC, Ruggero D (2010) Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancer. Clin Cancer Res 16:4914\u20134920","journal-title":"Clin Cancer Res"},{"key":"76_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4161\/rna.3.1.2718","volume":"3","author":"VA Polunovsky","year":"2006","unstructured":"Polunovsky VA, Bitterman PB (2006) The cap-dependent translation apparatus integrates and amplifies cancer pathways. RNA Biol 3:10\u201317","journal-title":"RNA Biol"},{"key":"76_CR10","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/345544a0","volume":"345","author":"A Lazaris-Karatzas","year":"1990","unstructured":"Lazaris-Karatzas A, Montine KS, Sonenberg N (1990) Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5\u2032 cap. Nature 345:544\u2013547","journal-title":"Nature"},{"key":"76_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ccr.2004.05.024","volume":"5","author":"S Avdulov","year":"2004","unstructured":"Avdulov S, Li S, Michalek V et al (2004) Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell 5:553\u2013563","journal-title":"Cancer Cell"},{"key":"76_CR12","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1158\/0008-5472.CAN-08-3472","volume":"69","author":"JR Graff","year":"2009","unstructured":"Graff JR, Konicek BW, Lynch RL et al (2009) eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival. Cancer Res 69:3866\u20133873","journal-title":"Cancer Res"},{"key":"76_CR13","doi-asserted-by":"publisher","first-page":"4256","DOI":"10.1158\/0008-5472.CAN-05-2879","volume":"66","author":"BA Jacobson","year":"2006","unstructured":"Jacobson BA, Alter MD, Kratzke MG et al (2006) Repression of cap-dependent translation attenuates the transformed phenotype in non-small cell lung cancer both in vitro and in vivo. Cancer Res 66:4256\u20134262","journal-title":"Cancer Res"},{"key":"76_CR14","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1038\/sj.bjc.6605044","volume":"100","author":"LJ Coleman","year":"2009","unstructured":"Coleman LJ, Peter MB, Teall TJ et al (2009) Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity. Br J Cancer 100:1393\u20131399","journal-title":"Br J Cancer"},{"key":"76_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/jso.20037","volume":"86","author":"CN Chen","year":"2004","unstructured":"Chen CN, Hsieh FJ, Cheng YM, Lee PH, Chang KJ (2004) Expression of eukaryotic initiation factor 4E in gastric adenocarcinoma and its association with clinical outcome. J Surg Oncol 86:22\u201327","journal-title":"J Surg Oncol"},{"key":"76_CR16","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1038\/sj.onc.1202563","volume":"18","author":"IB Rosenwald","year":"1999","unstructured":"Rosenwald IB, Chen JJ, Wang S, Savas L, London IM, Pullman J (1999) Upregulation of protein synthesis initiation factor eIF-4E is an early event during colon carcinogenesis. Oncogene 18:2507\u20132517","journal-title":"Oncogene"},{"key":"76_CR17","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.cellbi.2007.06.006","volume":"31","author":"Z Salehi","year":"2007","unstructured":"Salehi Z, Mashayekhi F, Shahosseini F (2007) Significance of eIF4E expression in skin squamous cell carcinoma. Cell Biol Int 31:1400\u20131404","journal-title":"Cell Biol Int"},{"key":"76_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0002-9440(10)65118-8","volume":"155","author":"S Wang","year":"1999","unstructured":"Wang S, Rosenwald IB, Hutzler MJ et al (1999) Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin\u2019s lymphomas. Am J Pathol 155:247\u2013255","journal-title":"Am J Pathol"},{"key":"76_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ijc.10180","volume":"98","author":"C Bauer","year":"2002","unstructured":"Bauer C, Brass N, Diesinger I, Kayser K, Grasser FA, Meese E (2002) Overexpression of the eukaryotic translation initiation factor 4G (eIF4G-1) in squamous cell lung carcinoma. Int J Cancer 98:181\u2013185","journal-title":"Int J Cancer"},{"key":"76_CR20","first-page":"2489","volume":"20","author":"M Shuda","year":"2000","unstructured":"Shuda M, Kondoh N, Tanaka K et al (2000) Enhanced expression of translation factor mRNAs in hepatocellular carcinoma. Anticancer Res 20:2489\u20132494","journal-title":"Anticancer Res"},{"key":"76_CR21","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/JTO.0b013e31811f3aab","volume":"2","author":"MR Patel","year":"2007","unstructured":"Patel MR, Jacobson BA, De A et al (2007) Ras pathway activation in malignant mesothelioma. J Thorac Oncol 2:789\u2013795","journal-title":"J Thorac Oncol"},{"key":"76_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/sj.bjc.6605184","volume":"101","author":"BA Jacobson","year":"2009","unstructured":"Jacobson BA, De A, Kratzke MG et al (2009) Activated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma. Br J Cancer 101:424\u2013431","journal-title":"Br J Cancer"},{"key":"76_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.cell.2006.11.046","volume":"128","author":"NJ Moerke","year":"2007","unstructured":"Moerke NJ, Aktas H, Chen H et al (2007) Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G. Cell 128:257\u2013267","journal-title":"Cell"},{"key":"76_CR24","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1073\/pnas.1011477108","volume":"108","author":"R Cencic","year":"2010","unstructured":"Cencic R, Hall DR, Robert F et al (2010) Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F. Proc Natl Acad Sci U S A 108:1046\u20131051","journal-title":"Proc Natl Acad Sci U S A"},{"key":"76_CR25","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0960-9822(00)00567-4","volume":"10","author":"TP Herbert","year":"2000","unstructured":"Herbert TP, Fahraeus R, Prescott A, Lane DP, Proud CG (2000) Rapid induction of apoptosis mediated by peptides that bind initiation factor eIF4E. Curr Biol 10:793\u2013796","journal-title":"Curr Biol"},{"key":"76_CR26","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1158\/1078-0432.CCR-08-2924","volume":"15","author":"SY Ko","year":"2009","unstructured":"Ko SY, Guo H, Barengo N, Naora H (2009) Inhibition of ovarian cancer growth by a tumor-targeting peptide that binds eukaryotic translation initiation factor 4E. Clin Cancer Res 15:4336\u20134347","journal-title":"Clin Cancer Res"},{"key":"76_CR27","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1172\/JCI32044","volume":"117","author":"JR Graff","year":"2007","unstructured":"Graff JR, Konicek BW, Vincent TM et al (2007) Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. J Clin Invest 117:2638\u20132648","journal-title":"J Clin Invest"},{"key":"76_CR28","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1097\/00005537-200006000-00007","volume":"110","author":"RJ DeFatta","year":"2000","unstructured":"DeFatta RJ, Nathan CA, De Benedetti A (2000) Antisense RNA to eIF4E suppresses oncogenic properties of a head and neck squamous cell carcinoma cell line. Laryngoscope 110:928\u2013933","journal-title":"Laryngoscope"},{"key":"76_CR29","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1158\/1535-7163.MCT-07-2357","volume":"7","author":"A Soni","year":"2008","unstructured":"Soni A, Akcakanat A, Singh G et al (2008) eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling. Mol Cancer Ther 7:1782\u20131788","journal-title":"Mol Cancer Ther"},{"key":"76_CR30","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1021\/mp300699d","volume":"10","author":"S Li","year":"2013","unstructured":"Li S, Jia Y, Jacobson B et al (2013) Treatment of breast and lung cancer cells with a N-7 benzyl guanosine monophosphate tryptamine phosphoramidate pronucleotide (4Ei-1) results in chemosensitization to gemcitabine and induced eIF4E proteasomal degradation. Mol Pharm 10:523\u2013531","journal-title":"Mol Pharm"},{"key":"76_CR31","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.ejmech.2009.11.054","volume":"45","author":"Y Jia","year":"2010","unstructured":"Jia Y, Chiu TL, Amin EA, Polunovsky V, Bitterman PB, Wagner CR (2010) Design, synthesis and evaluation of analogs of initiation factor 4E (eIF4E) cap-binding antagonist Bn7-GMP. Eur J Med Chem 45:1304\u20131313","journal-title":"Eur J Med Chem"},{"key":"76_CR32","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.leukres.2009.07.043","volume":"34","author":"R Cencic","year":"2009","unstructured":"Cencic R, Carrier M, Trnkus A, Porco JA Jr, Minden M, Pelletier J (2009) Synergistic effect of inhibiting translation initiation in combination with cytotoxic agents in acute myelogenous leukemia cells. Leuk Res 34:535\u2013541","journal-title":"Leuk Res"},{"key":"76_CR33","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10549-008-9956-x","volume":"113","author":"K Dong","year":"2009","unstructured":"Dong K, Wang R, Wang X et al (2009) Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells. Breast Cancer Res Treat 113:443\u2013456","journal-title":"Breast Cancer Res Treat"},{"key":"76_CR34","doi-asserted-by":"publisher","first-page":"e81669","DOI":"10.1371\/journal.pone.0081669","volume":"8","author":"BA Jacobson","year":"2013","unstructured":"Jacobson BA, Thumma SC, Jay-Dixon J et al (2013) Targeting eukaryotic translation in mesothelioma cells with an eIF4E-specific antisense oligonucleotide. PLoS One 8:e81669","journal-title":"PLoS One"},{"key":"76_CR35","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1158\/1535-7163.MCT-11-0530","volume":"11","author":"PB Bitterman","year":"2012","unstructured":"Bitterman PB, Polunovsky VA (2012) Attacking a nexus of the oncogenic circuitry by reversing aberrant eIF4F-mediated translation. Mol Cancer Ther 11:1051\u20131061","journal-title":"Mol Cancer Ther"},{"key":"76_CR36","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.4161\/cc.11.6.19610","volume":"11","author":"PB Bitterman","year":"2012","unstructured":"Bitterman PB, Polunovsky VA (2012) Translational control of cell fate: from integration of environmental signals to breaching anticancer defense. Cell Cycle 11:1097\u20131107","journal-title":"Cell Cycle"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-014-0076-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-014-0076-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-014-0076-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-014-0076-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T04:51:21Z","timestamp":1678510281000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-014-0076-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,9]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["76"],"URL":"https:\/\/doi.org\/10.1007\/s10637-014-0076-7","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,9]]},"assertion":[{"value":"4 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}